NTSR2

NTSR2 is a G protein-coupled neurotensin receptor that modulates neurotensinergic signaling and contributes to nociceptive processing (PMID:14725975). It heterodimerizes with NTSR1 through its TM2-TM4 region, and this interaction suppresses NTSR1-mediated adenylate cyclase/cAMP and phospholipase C signaling while causing intracellular retention of NTSR1, positioning NTSR2 as a negative regulator of NTSR1 surface expression and output (PMID:19968961). In glioma cells, neurotensin binding drives ERK1/2 phosphorylation through a mechanism that requires internalization of the neurotensin/NTSR2 complex, since blocking internalization with levocabastine abolishes ERK1/2 activation (PMID:25772140). At the organismal level, Ntsr2-knockout mice show altered thermal nociception distinct from Ntsr1-deficient animals, and NTSR2 function is regulated by NTSR3/sortilin, whose loss elevates brain NTSR2 protein and neurotensin while conferring resistance to thermal and chemical pain (PMID:14725975, PMID:27932946). Beyond neuronal signaling, NTSR2 physically interacts with TrkB in chronic lymphocytic leukemia B-cells to form an oncogenic complex that activates Src family kinase and anti-apoptotic signaling, an interaction disruptable by a peptide targeting the binding interface (PMID:38480783).

1. 2001 Medium

   Defining the Ntsr2 gene architecture and promoter established the transcriptional and splicing basis for receptor expression, including a truncated isoform.

   Evidence Genomic cloning, primer extension, and promoter sequence analysis in mouse

   PMID:11687289

   Open questions at the time

   • Functional consequence of the truncated isoform unresolved
   • Regulatory elements not tied to specific tissue expression patterns
2. 2004 Medium

   Knockout of Ntsr2 assigned the receptor a specific role in thermal nociception distinct from NTSR1, separating the two subtypes functionally in vivo.

   Evidence Ntsr2 knockout mice with hot plate, tail flick, and hind paw licking assays plus mRNA distribution mapping

   PMID:14725975

   Open questions at the time

   • Cellular circuit and downstream signaling mediating the phenotype not defined
   • Single behavioral paradigm dominated the positive finding
3. 2009 Medium

   Demonstration that NTSR2 heterodimerizes with NTSR1 and suppresses its signaling revealed a mechanism by which NTSR2 negatively regulates a related receptor subtype.

   Evidence Reciprocal Co-IP of epitope-tagged receptors, chimeric domain mapping, cAMP/PLC assays, and confocal microscopy

   PMID:19968961

   Open questions at the time

   • Physiological relevance of the heterodimer in vivo not tested
   • Whether dimerization affects NTSR2's own signaling unknown
4. 2015 Medium

   Linking NTSR2 internalization to ERK1/2 activation in glioma identified an internalization-dependent route for neurotensin-driven mitogenic signaling.

   Evidence Levocabastine pharmacological blockade and ERK1/2 phosphorylation assays in C6 glioma cells

   PMID:25772140

   Open questions at the time

   • Reliance on antagonist specificity for mechanistic conclusion
   • G protein versus arrestin contribution not dissected
5. 2016 Medium

   Showing that NTSR3/sortilin loss elevates NTSR2 and neurotensin and confers pain resistance placed NTSR2 within a regulatory network controlling nociception.

   Evidence NTSR3 knockout mice with qPCR, Western blot, AlphaLisa quantification, and thermal/chemical pain assays

   PMID:27932946

   Open questions at the time

   • Direct physical NTSR2-NTSR3 interaction not demonstrated here
   • Mechanism of NTSR2 protein level regulation unresolved
6. 2024 Medium

   Identifying an NTSR2-TrkB complex in CLL B-cells extended NTSR2 function to oncogenic survival signaling and offered a disruptable interaction interface.

   Evidence Binding domain mapping, interface-targeting peptide, Co-IP, Src family kinase analysis, and viability assays in MEC-1 cells and 30 CLL patient samples

   PMID:38480783

   Open questions at the time

   • Whether neurotensin ligand is required for the complex unclear
   • Structural basis of the binding domain not resolved

• How NTSR2 couples to G proteins versus internalization-dependent pathways across cell types, and whether its heterodimerization and TrkB interactions operate in the same physiological settings, remains unresolved.
• No structural model of NTSR2 or its complexes
• Endogenous ligand-dependence of TrkB and NTSR1 interactions undefined
• In vivo relevance of dimerization-based NTSR1 suppression untested